Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma

por Mahdy, Ahmed, Hamoda, Asmaa, Zaher, Ahmed, Khorshed, Eman, Elwakeel, Madeha, Hassanein, Omneya, Sidhom, Iman
Publicado 2023

PB2254: TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDREN AND ADOLESCENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

por Ali, Nesreen, Moussa, Emad, Rahman, Hany Abdel, Hafez, Hanafy, Zaghloul, Mohamed S, Khorshed, Eman, Elwakeel, Madeha, Mehesen, Maha, Hammad, Mahmoud
Publicado 2023